Vital Therapies (VTL) Reports In-Line Q3 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- Tech selloff weighs down Wall Street as bond yields climb
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Tech selloff weighs down Wall Street as bond yields climb
- Francisco Partners to acquire Weave Communications for $650M
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Goldman Sachs to acquire real estate company LCN for up to $410M
- BofA raises hyperscaler AI capex outlook to $3.6tn through 2028
Vital Therapies Announces Third Quarter Financial Results
November 3, 2016 4:01 PM EDTSAN DIEGO, Nov. 03, 2016 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq: VTL), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver failure, today announced results for the third quarter ended September 30, 2016.
Key Recent Developments
Twenty subjects have been enrolled at sites in the United States and Europe in VTL-308, the Companys phase 3 randomized, controlled, open-label trial, designed to evaluate the ELAD System in... MoreInvesco Closed-End Funds Declare Dividends
November 1, 2016 1:16 PM EDTATLANTA, Nov. 1, 2016 /PRNewswire/ -- The Board of Trustees of each of the Invesco closed-end funds listed below today declared the following dividends.
                                                                Â
EX-DATEÂ Â Â Â Â RECORD DATE
11/10/16Â Â Â Â Â Â Â 11/14/16Â Â Â
REINVEST DATE11/30/16
PAYABLE DATE11/30/16
Name of... More
